{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:25:45Z","timestamp":1767705945582},"reference-count":38,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2023.2653","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T12:10:18Z","timestamp":1686658218000},"source":"Crossref","is-referenced-by-count":2,"title":["Treating radiation\u2011related nasopharyngeal necrosis with endostar in patient with nasopharyngeal carcinoma: A report of two cases and a literature review"],"prefix":"10.3892","volume":"19","author":[{"given":"Jie","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Oncology, Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, Guangdong 511400, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Wen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Panyu Central Hospital, Guangzhou, Guangdong 511400, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital, School of Medicine, South China University of Technology Guangzhou, Guangzhou, Guangdong 510180, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, Guangdong 511400, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, Guangdong 511400, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Wen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, Guangdong 511400, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Long","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, Guangdong 511400, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, Guangdong 511400, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-Cheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Rong","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, Guangdong 511400, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"key20230628100443_b1-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10654-007-9148-8","article-title":"Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997","volume":"22","author":"Luo","year":"2007","journal-title":"Eur J Epidemiol"},{"issue":"e045417","key":"key20230628100443_b2-MCO-19-1-02653","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045417","article-title":"Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: A population-based retrospective study","volume":"11","author":"Xu","year":"2021","journal-title":"BMJ Open"},{"key":"key20230628100443_b3-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","article-title":"Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up","volume":"51","author":"Zhang","year":"2015","journal-title":"Eur J Cancer"},{"key":"key20230628100443_b4-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/bjc.2013.720","article-title":"Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: Patient and treatment-related risk factors","volume":"110","author":"Zeng","year":"2014","journal-title":"Br J Cancer"},{"key":"key20230628100443_b5-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.2147\/CMAR.S197841","article-title":"The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: A large-scale cohort study","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag Res"},{"key":"key20230628100443_b6-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ijrobp.2018.06.027","article-title":"Osteoradionecrosis of the Skull base in nasopharyngeal carcinoma: Incidence and risk factors","volume":"102","author":"Han","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1139","key":"key20230628100443_b7-MCO-19-1-02653","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5055-5","article-title":"Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma","volume":"18","author":"Kong","year":"2018","journal-title":"BMC Cancer"},{"key":"key20230628100443_b8-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clon.2011.11.010","article-title":"Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy","volume":"24","author":"Han","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20230628100443_b9-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"533","DOI":"10.5732\/cjc.012.10252","article-title":"Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis","volume":"32","author":"Chen","year":"2013","journal-title":"Chin J Cancer"},{"key":"key20230628100443_b10-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1097\/01.mlg.0000230435.71328.b9","article-title":"Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma","volume":"116","author":"Huang","year":"2006","journal-title":"Laryngoscope"},{"key":"key20230628100443_b11-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.02.012","article-title":"Proposal for a new risk classification system for nasopharyngeal carcinoma patients with post-radiation nasopharyngeal necrosis","volume":"67","author":"Yang","year":"2017","journal-title":"Oral Oncol"},{"key":"key20230628100443_b12-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/hed.24973","article-title":"Role of surgery in the treatment of osteoradionecrosis and its complications after radiotherapy for nasopharyngeal carcinoma","volume":"40","author":"Huang","year":"2018","journal-title":"Head Neck"},{"key":"key20230628100443_b13-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1002\/ijc.31217","article-title":"A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01)","volume":"142","author":"Chen","year":"2018","journal-title":"Int J Cancer"},{"key":"key20230628100443_b14-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.radonc.2014.11.039","article-title":"Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer","volume":"114","author":"Bao","year":"2015","journal-title":"Radiother Oncol"},{"key":"key20230628100443_b15-MCO-19-1-02653","first-page":"854","article-title":"A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)","volume":"33","author":"Han","year":"2011","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20230628100443_b16-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3779\/j.issn.1009-3419.2005.04.07","article-title":"(Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients)","volume":"8","author":"Wang","year":"2005","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"key20230628100443_b17-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"33926","DOI":"10.18632\/oncotarget.5271","article-title":"The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma","volume":"6","author":"Guan","year":"2015","journal-title":"Oncotarget"},{"key":"key20230628100443_b18-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2147\/OTT.S190409","article-title":"Successful treatment of brain radiation necrosis resulting from triple-negative breast cancer with Endostar and short-term hyperbaric oxygen therapy: A case report","volume":"12","author":"Xing","year":"2019","journal-title":"Onco Targets Ther"},{"key":"key20230628100443_b19-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3892\/mmr.2012.903","article-title":"Protection against acute radiation-induced lung injury: A novel role for the anti-angiogenic agent Endostar","volume":"6","author":"Zhang","year":"2012","journal-title":"Mol Med Rep"},{"issue":"327","key":"key20230628100443_b20-MCO-19-1-02653","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08036-8","article-title":"Comparing the 7th and 8th editions of UICC\/AJCC staging system for nasopharyngeal carcinoma in the IMRT era","volume":"21","author":"He","year":"2021","journal-title":"BMC Cancer"},{"key":"key20230628100443_b21-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/cncr.29795","article-title":"Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy","volume":"122","author":"Pan","year":"2016","journal-title":"Cancer"},{"key":"key20230628100443_b22-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/hed.21036","article-title":"Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma","volume":"31","author":"Hua","year":"2009","journal-title":"Head Neck"},{"key":"key20230628100443_b23-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10147-018-1354-8","article-title":"Endoscopic sequestrectomy for skull base osteoradionecrosis in nasopharyngeal carcinoma patients: A 10-year experience","volume":"24","author":"Liu","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"key20230628100443_b24-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ijrobp.2010.03.029","article-title":"Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): A phase II trial","volume":"80","author":"Delanian","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20230628100443_b25-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.anorl.2013.11.006","article-title":"Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: Preliminary results","volume":"131","author":"Robard","year":"2014","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"key20230628100443_b26-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bjoms.2008.04.006","article-title":"Osteoradionecrosis of the jaws: Current understanding of its pathophysiology and treatment","volume":"46","author":"Lyons","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key20230628100443_b27-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1158\/1078-0432.CCR-03-0426","article-title":"Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: A role for vascular endothelial growth factor","volume":"10","author":"Nordal","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20230628100443_b28-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0092-8674(00)81848-6","article-title":"Endostatin: An endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"key20230628100443_b29-MCO-19-1-02653","first-page":"1793","article-title":"Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors","volume":"60","author":"Perletti","year":"2000","journal-title":"Cancer Res"},{"key":"key20230628100443_b30-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1126\/science.284.5415.808","article-title":"Effects of angiogenesis inhibitors on multistage carcinogenesis in mice","volume":"284","author":"Bergers","year":"1999","journal-title":"Science"},{"key":"key20230628100443_b31-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/37126","article-title":"Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance","volume":"390","author":"Boehm","year":"1997","journal-title":"Nature"},{"key":"key20230628100443_b32-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1200\/JCO.2006.05.6762","article-title":"Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors","volume":"24","author":"Kulke","year":"2006","journal-title":"J Clin Oncol"},{"issue":"e34646","key":"key20230628100443_b33-MCO-19-1-02653","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034646","article-title":"Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models","volume":"7","author":"Peng","year":"2012","journal-title":"PLoS One"},{"key":"key20230628100443_b34-MCO-19-1-02653","first-page":"407","article-title":"Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound","volume":"25","author":"Wang","year":"2020","journal-title":"J BUON"},{"issue":"e12750","key":"key20230628100443_b35-MCO-19-1-02653","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012750","article-title":"Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors","volume":"97","author":"Cheng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"key20230628100443_b36-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00280-011-1576-1","article-title":"Phase II study of cisplatin\/etoposide and endostar for extensive-stage small-cell lung cancer","volume":"68","author":"Zhou","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"15330338211064434","key":"key20230628100443_b37-MCO-19-1-02653","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211064434","article-title":"Tolerance and pharmacokinetics of recombinant human endostatin administered as single-dose or multiple-dose infusions in patients with advanced solid tumors: A phase I clinical trial","volume":"20","author":"Wang","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"key20230628100443_b38-MCO-19-1-02653","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1200\/JCO.2002.02.082","article-title":"Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily","volume":"20","author":"Eder","year":"2002","journal-title":"J Clin Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T10:04:51Z","timestamp":1687946691000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2023.2653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,13]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2023.2653","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"article-number":"57"}}